A small UK-based pharmaceutical company, Synairgen Plc, has announced that its drug significantly reduces the risk of severe symptoms of Covid-19 caused by the coronavirus.

Contrary to popular belief, monetary policy does not lack ammunition. The ECB may lower interest rates, implement a special program of long-term refinancing operations (LTRO) for small and medium-sized enterprises - [...]

The main factor shaping the situation on commodity markets is still news related to the Covid-19 virus and the potential risk of its spread throughout Asia and abroad. China, which [...]